Press "esc" to clear
Go to Advanced Search

Showing results

110 of 42
  • Embargo expired:
    5-Oct-2016 4:00 PM EDT

Article ID: 662208

Medical Societies, Advocacy Groups Develop Genetics Toolkit

Society of Gynecologic Oncology

The Society of Gynecologic Oncology (SGO) convened experts from the American College of Obstetricians and Gynecologists (ACOG), National Society of Genetic Counselors, Bright Pink and Facing Our Risk of Cancer Empowered (FORCE), to develop the SGO Genetics Toolkit.

Released:
5-Oct-2016 4:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 658977

ASCO and SGO Issue New Guidelines for Treating Ovarian Cancer

Society of Gynecologic Oncology

The American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) jointly issued new clinical practice guidelines for the treatment of patients with ovarian cancer.1

Released:
12-Aug-2016 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
Fowler_Jeffrey.jpg
  • Embargo expired:
    22-Mar-2016 8:00 AM EDT

Article ID: 650009

Dr. Jeffrey Fowler Begins SGO Presidency

Society of Gynecologic Oncology

effrey Fowler, MD, John G. Boutselis Chair in Gynecologic Oncology and Professor and vice-chair of Obstetrics and Gynecology at The Ohio State University Wexner Medical Center in Columbus, started his one-year term as the 48th President of the Society of Gynecologic Oncology (SGO) today at the conclusion of the Society’s 47th Annual Meeting on Women’s Cancer in San Diego.

Released:
22-Mar-2016 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
Birrerphoto.jpg
  • Embargo expired:
    21-Mar-2016 8:00 AM EDT

Article ID: 650109

Dr. Michael Birrer Named Recipient of the 2016 Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher

Society of Gynecologic Oncology

The Claudia Cohen Research Foundation and the Foundation for Women’s Cancer announced today that Michael J. Birrer, MD, PhD, has been selected as the 2016 recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher.

Released:
21-Mar-2016 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 648269

SGO Names New CEO for Society and Foundation

Society of Gynecologic Oncology

The Society of Gynecologic Oncology has appointed Pierre M. Désy, MPH, CAE, as Chief Executive Officer of the Society and its Foundation for Women’s Cancer, effective April 25, 2016.

Released:
22-Feb-2016 10:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 645501

SGO’s Foundation for Gynecologic Oncology Merges with Foundation for Women’s Cancer

Society of Gynecologic Oncology

Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation within the SGO.

Released:
4-Jan-2016 3:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Channels:

Local - Illinois

ColemanOfficialPhotoforPresidency2015.jpg

Article ID: 632514

Dr. Robert Coleman Begins SGO and Foundation Presidency

Society of Gynecologic Oncology

Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.

Released:
10-Apr-2015 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
  • Embargo expired:
    28-Mar-2015 8:50 AM EDT

Article ID: 631752

Immunotherapy Delays Recurrence for Stage III and IV Ovarian Cancers

Society of Gynecologic Oncology

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the cancer’s return.

Released:
27-Mar-2015 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Comment
  • Embargo expired:
    8-Jan-2015 1:00 AM EST

Article ID: 627920

Medical Societies Recommend Consideration of Primary HPV Testing for Cervical Cancer Screening

Society of Gynecologic Oncology

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing.

Released:
8-Jan-2015 1:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Article ID: 626698

FDA Approval of Nonavalent HPV Vaccine Adds New Tool to Eradicate Cervical Cancer

Society of Gynecologic Oncology

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).

Released:
10-Dec-2014 4:30 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment

Showing results

110 of 42





Chat now!